Bladder Cancer Trial, Recruiting NCT07037589 Sponsor: Vastra Gotaland Region Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT07037589
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women aged 50 or older
  • People who have visible blood in their urine (urine that appears red, pink, or brown)
  • People who are attending a specialist clinic specifically for the assessment of visible blood in their urine
  • People who are able to understand and agree to participate in the study

Who may not be able to join:

  • People who have previously been diagnosed with bladder cancer, kidney cancer, or cancer of the upper urinary tract
  • People whose memory or thinking difficulties would prevent them from giving informed consent to participate
  • People who are currently receiving or have recently received treatment for a urological (urinary system) cancer
  • People with serious health conditions that the trial site determines could affect their ability to participate safely (confirm with trial site)
  • People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Suleiman Abuhasanein, Department of Urology, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg

Phone: 0104353572

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Vastra Gotaland Region
Registry
ClinicalTrials.gov
Start date
13 October 2025
Est. completion
30 August 2026

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Incidence of urological malignancy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov